CD3+CD56+ T cell and CD14+ HLA-DR phenotypes demonstrate differential abundance and contributions to clinical parameters in ALS patients and thus may reveal mechanistic insights into the pathology of the disease. Here, CD14 is linked to amyotrophic lateral sclerosis.